Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Issued (2016 - 2025)

Historic Shares Issued for Anika Therapeutics (ANIK) over the last 16 years, with Q2 2025 value amounting to $261000.0.

  • Anika Therapeutics' Shares Issued fell 3273.2% to $261000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $558000.0, marking a year-over-year decrease of 2657.89%. This contributed to the annual value of $708000.0 for FY2024, which is 1204.97% down from last year.
  • Anika Therapeutics' Shares Issued amounted to $261000.0 in Q2 2025, which was down 3273.2% from $297000.0 recorded in Q4 2024.
  • Anika Therapeutics' 5-year Shares Issued high stood at $650000.0 for Q4 2022, and its period low was $7000.0 during Q1 2023.
  • For the 5-year period, Anika Therapeutics' Shares Issued averaged around $297250.0, with its median value being $323000.0 (2023).
  • Per our database at Business Quant, Anika Therapeutics' Shares Issued plummeted by 9217.03% in 2021 and then skyrocketed by 47017.54% in 2022.
  • Anika Therapeutics' Shares Issued (Quarter) stood at $114000.0 in 2021, then surged by 470.18% to $650000.0 in 2022, then tumbled by 46.31% to $349000.0 in 2023, then fell by 14.9% to $297000.0 in 2024, then decreased by 12.12% to $261000.0 in 2025.
  • Its Shares Issued stands at $261000.0 for Q2 2025, versus $297000.0 for Q4 2024 and $388000.0 for Q2 2024.